Clinical Trial Update: Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases [Phase 1]

View source ↗

Summary

This report notes the completion of a Phase 1 trial evaluating the safety and tolerability of intravenous CRS-100 in adults with carcinoma and liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Liver Metastases
• Liver Neoplasms

Drugs mentioned

• CRS-100 (CRS-100)

Snippet

Sponsor: Anza Therapeutics, Inc. | Conditions: Neoplasm Metastasis, Liver Neoplasms | Phase 1 | Status: COMPLETED